Alzheimer Disease, Dementia With Lewy Bodies, Frontotemporal Dementia
Conditions
Brief summary
Double blinded, sham-controlled, randomized trial on repeated transcranial alternating current brain stimulation (tACS) in neurodegenerative diseases. The investigators will evaluate whether a 4-times daily repeated stimulation with gamma tACS on the posterior parietal cortex can improve symptoms in patients with neurodegenerative diseases, including dementia with Lewy Bodies, Alzheimer's disease, idiopathic normal pressure hydrocephalus and Frontotemporal dementia.
Detailed description
Double blinded, sham-controlled, randomized trial on repeated transcranial alternating current brain stimulation (tACS) in neurodegenerative diseases. The investigators will evaluate whether a 4-times daily repeated stimulation with gamma tACS on the posterior parietal cortex can improve symptoms in patients with neurodegenerative diseases, including dementia with Lewy Bodies, Alzheimer's disease, idiopathic normal pressure hydrocephalus and Frontotemporal dementia.
Interventions
Single session of gamma tACS (40 Hz) over the superior parietal cortex
Sponsors
Study design
Eligibility
Inclusion criteria
* Mild Cognitive Impairment due to Alzheimer's disease * Dementia with Lewy Bodies * Frontotemporal dementia * Idiopathic normal pressure hydrocephalus (iNPH)
Exclusion criteria
* History of seizures * Pregnancy * Metal implants in the head (except dental fillings) * Electronic implants (i.e. pace-maker, implanted medical pump) * Age \<18 years
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Changes in phonemic fluency | Baseline (immediately before the intervention), immediately after the first intervention, immediately after the 4th intervention, 4 weeks after the last intervention | Person is requested to provide as many words as possible starting with certain letter. The score is the sum of all acceptable words produced in one minute. |
| Changes in orientation to time and place (MMSE questions 1-10) | Baseline (immediately before the intervention), immediately after the last intervention, 4 weeks after the last intervention | 10 questions about the orientation. The score ranges from 0 (worse performance) to 10 (best performance). |
| Changes in Trail Making A & B tests | Baseline (immediately before the intervention), immediately after the 4th intervention, 4 weeks after the last intervention | TMT A & B tests. Time to perform set is recorded. |
| Changes in INECO Frontal Screening test | Baseline (immediately before the intervention), immediately after the 4th intervention, 4 weeks after the last intervention | Test battery assessing frontal lobe functions. The score ranges from 0 (worse performance) to 30 (best performance) |
| Changes in Rey Auditory Verbal Learning Test score | Baseline (immediately before the intervention), immediately after the first intervention, immediately after the 4th intervention, 4 weeks after the last intervention | Participants are given a list of 15 unrelated words repeated over five different trials and are asked to repeat. Another list of 15 unrelated words are given and the patient must again repeat the original list of 15 words and then again after 30 minutes. The examiner reads aloud 15 unrelated words and the participant is asked to recall the words after each of the five trials. After a 15 minute delay, the participant is asked again to recall the words. The score ranges from 0 (worst performance) to 75 (best performance). |
| Changes in Rey Auditory Verbal Learning Test, recognition | Baseline (immediately before the intervention), immediately after the first intervention, immediately after the 4th intervention, 4 weeks after the last intervention | Participants are given a list of 15 unrelated words repeated over five different trials and are asked to repeat. After a 15 minute delay, the participant is asked to recognise the original 15 words intermixed with 31 distractor words. The score of the recognition part ranges from 0 (worst performance) to 46 (best performance). |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Change in SICI measurements | Baseline (immediately before the intervention), immediately after the last intervention | By using transcranial magnetic stimulation (TMS), the investigators will evaluate the effects of gamma tACS on short interval intracortical inhibition (SICI), which is a marker of gabaergic neurotransmission. |
| Change in ICF measurements | Baseline (immediately before the intervention), immediately after the last intervention | By using transcranial magnetic stimulation (TMS), the investigators will evaluate the effects of gamma tACS on intracortical facilitation (ICF), which is a marker of glutamatergic neurotransmission. |
| Change in SAI measurements | Baseline (immediately before the intervention), immediately after the last intervention | By using transcranial magnetic stimulation (TMS), the investigators will evaluate the effects of gamma tACS on short latency afferent inhibition (SAI), which is a marker of cholinergic neurotransmission. |
Countries
Finland